The 0.9% concentration is carefully chosen to balance two competing demands: Antimicrobial efficacy: The concentration must be sufficient to inhibit common lab contaminants, including gram-positive and gram-negative bacteria as well as common fungal species
Third-Party Testing Because the FDA does not regulate supplements, third-party testing provides independent verification of a NAD+ supplements safety, purity, and label accuracy
In heterodimeric GST complexes such as those formed by the cytosolic mu and alpha classes, however, the cleft between the two subunits is home to an additional high-affinity nonsubstrate xenobiotic binding site, which may account for the enzymes' ability to form heterodimers
Thats why experienced clinicians dont begin by asking, Which peptide should we use? They begin by asking, What are we treating? That distinction influences every decision that follows, including whether peptide therapy is appropriate at all